Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 731 | 156 | 437 | 488 | 237 |
| Operating Income | -731 | -156 | -437 | -488 | -237 |
| Interest Expense | 72 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 318 | 750 | 983 | 530 |
| Pre-tax Income | -803 | 163 | 313 | 494 | 293 |
| Income Tax | 6 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -809 | 163 | 313 | 494 | 293 |
| Minority Interests | -22 | N/A | N/A | N/A | N/A |
| Net Income | $-787 | $163 | $313 | $494 | $293 |
| EPS Basic Total Ops | -105.26 | -13.49 | -12.15 | -2.70 | -2.70 |
| EPS Basic Continuous Ops | -108.52 | 6.55 | 12.60 | 19.89 | 11.77 |
| EPS Diluted Total Ops | -105.26 | -13.49 | -12.15 | -2.70 | -2.70 |
| EPS Diluted Continuous Ops | -108.52 | 6.55 | 12.60 | 19.89 | 11.77 |
| EBITDA(a) | $-731 | $-156 | $-437 | $-488 | $-237 |